Aspectos epidemiológicos da espécie Acinetobacter baumannii no controle de infecções relacionadas à assistência à saúde: uma revisão da literatura

Abstract

A group of bacteria stands out for the profile of antimicrobial resistance as well as for its role in health care related infections which is called ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp). In this group, the bacterium Acinetobacter baumannii, which can be a producer of carbapenemase, is resistant to several antimicrobials, with mechanisms that defeat the host's defenses, with nutritional versatility and also adaptable to hospital environments. Know your taxonomy; the most relevant genes such as blaoxa-51 and blaoxa-23, its ability to form biofilm; the mechanisms of interaction with the host; the recommendations of the monitoring agencies and the treatments currently advocated is essential to identify more efficient ways of combating and controlling the aforementioned microorganism, which is among the most important multiresistant bacteria in the world, making it necessary to research and discover new drugs for more efficient treatments for the patients, mainly the patients assisted in intensive care centers. Thus, health services must follow the norms advocated by ANVISA and the World Health Organization, bringing routines and protocols that aim to minimize and control multiresistant bacteria in the hospital environment, being essential for the proper control and treatment of these bacteria in said environments.